OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Alzheimers Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	155
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study	151
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	142
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	108
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	102
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	91
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	84
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	78
A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders	78
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan	74
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	71
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	62
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice	60
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	57
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	56
Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	55
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	54
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging	54
Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study	52
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	50
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	49
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	49
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	49
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic	48
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	48

Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial	47
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons	47
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	45
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	45
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	44
Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014)	43
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	43
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	43
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	41
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	39
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease	39
Needs of people living with young-onset dementia and family carers, explored by dementia subtype, phase in the disease process, and living setting: A scoping review	38
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	38
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	38
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	37
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	37
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	37
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	36
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	36
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	36
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	36
Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective	36
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	36
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	35
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks	34
Blood pressure dynamic instability and neurodegeneration in older adults	34
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	33
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	33
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	33
Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning	33
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	33
Incident Dementia After Spontaneous Intracerebral Hemorrhage	33
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	33
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	32
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	32
Hydrate to keep the amyloid away	32
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	32
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	32
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	32
Attentional Control in Subjective Cognitive Decline	31
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	31
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	31
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	31
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	31
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	30
Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer’s Disease	30
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	30
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	29
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others	29
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	29

Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	28
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	28
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	28
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	28
White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults	28
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	28
Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football	28
Methylcobalamin Alleviates Neuronal Apoptosis and Cognitive Decline Induced by PM2.5 Exposure in Mice	27
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	27
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	27
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	27
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	27
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	27
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	27
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	27
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies	27
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	27
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	26
Sleep disturbances and language function impairment in the elderly: Evidence of limbic and prefrontal tracts involvement	26
Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach	26
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	26
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1	26
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	26
Dementia in Denmark: Uncovering the causes of death and life years lost in a nationwide, register-based cohort study	26
HARMONISATION – A multimodal prospective study of vascular cognitive impairment in multi-ethnic Asians: Cohort profile, progress, current contributions, and future impact	26
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	26
Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy	26
α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease	26
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	25
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	25
One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques	25
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	25
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	25
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer’s Disease	25
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	25
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	25
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	25
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	24
Factors Associated with Apathy in Alzheimer’s Disease: A Cross-Sectional Analysis of the Texas Alzheimer’s Research and Care Consortium (TARCC) Study	24
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	24
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	24
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	24
A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients	24
The Diagnostic Value of a Short Memory Test: The TNI-93	24
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	24
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	24
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	24
Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award	24
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	24
Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer’s Disease and Cognitive Function	23
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	23
Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition	23
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	23
Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer’s Di	23
Hearing loss, plasma neurodegenerative biomarkers, and cognitive function: Independent and additive effects	23
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	23
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	23
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	23
The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET prediction	23
COVID-19 and Alzheimer’s Disease: What Is the Connection?	22
Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center	22
Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer’s Disease	22
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	22
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	22
Developing an Image-Based Deep Learning Framework for Automatic Scoring of the Pentagon Drawing Test	22
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	22
Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	22
Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease	22
Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study	22
Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study	22
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition	22
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentratio	22
The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review	22
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	22
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	22
No Influence of Age-Related Hearing Loss on Brain Amyloid-β	22
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	21
Efficacy of a Virtual Education Program for Family Caregivers of Persons Living with Dementia	21
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	21
Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study	21

Helicobacter pylori and Alzheimer's disease risk: The HUNT study	21
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	21
Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	21
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	21
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	21
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	21
Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	21
Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer’s Disease and Longitudinal Change in Hippocampus Function	21
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	21
GAPDH citrullination as a molecular signature of neurodegeneration, assessed in prion diseases	21
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	21
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	20
A Decade of Decline in Serious Cognitive Problems Among Older Americans: A Population-Based Study of 5.4 Million Respondents	20
Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer’s Disease	20
Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank	20
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease	20
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	20
Meaning in life and neurobiomarkers of brain health in the UK Biobank	20
Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States	20
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	20
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	20
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	20
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	20
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	20
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers	20
Evaluation of early-phase ¹⁸ F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with ¹⁸ F-FDG PE	20
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	20
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	20
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	19
Protocol for a Mixed-Methods Process Evaluation of BetterBrains: A Person-Centered Online Intervention to Delay Cognitive Decline in Adults at Risk of Dementia	19
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer’s Disease	19
Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study	19
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	19
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	19
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease	19
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)	19
Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults	19
Societal Costs of Dementia: 204 Countries, 2000–2019	19
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	19
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	19
The relationship between postoperative cognitive dysfunction and cerebral small vessel disease: A comprehensive review	19
Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease	19
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	19
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	19
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	19
An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease	18
Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries	18
Biomarkers and Mindfulness: A Way Forward	18
Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia	18
Digital Biomarkers for the Assessment of Non-Cognitive Symptoms in Patients with Dementia with Lewy Bodies: A Systematic Review	18
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	18
Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration	18
Towards characterizing subjective cognitive decline in older adults	18
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors	18
Sex differences in cognitive trajectories and practice effects in a cohort of older Londoners: The role of risk factors	18
Concerning the debate about homocysteine, B vitamins, and dementia	18
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort	18
Causal Association Between mTOR-Dependent Protein Levels and Alzheimer’s Disease: A Mendelian Randomization Study	18
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease	18
Projecting the Likely Impact of COVID-19 Infections on the Prevalence of Dementia in the United States	18
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment	18
Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer’s Disease Pathology	18
Identification of Major Cognitive Disorders in Self-Reported versus Administrative Health Data: A Cohort Study in Quebec	18
Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats	18
Hippocampal-Subregion Mechanisms of Repetitive Transcranial Magnetic Stimulation Causally Associated with Amelioration of Episodic Memory in Amnestic Mild Cognitive Impairment	18
The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease	18
Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease	18
Association Between High Serum Tetrahydrofolate and Low Cognitive Functions in the United States: A Cross-Sectional Study	18
Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia	18
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease	18
Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment	18
Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population	18
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	18
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation	18
Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1	17
Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid	17
Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer’s Disease	17
Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers	17
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer’s Disease	17
Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-β and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro	17
Diffusion Imaging of Gray Matter Microstructure in Alzheimer’s Disease	17
Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer’s Disease and Related Dementias: A Cluster Analysis	17
Association of Age with Dual-Task Objective Cognitive Indicators and Gait Parameters in Older Adults	17
Loneliness, Dementia Status, and Their Association with All-Cause Mortality Among Older US Adults	17
Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study	17
Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome	17
A Longitudinal Study of Functional Unmet Need Among People with Dementia	17
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy	17
Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells	17
Toward Pre-Diagnostic Detection of Dementia in Primary Care	17
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome	17
Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)	17
Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain	17
Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer’s Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle	17
The role of vitamins in dementia prevention and cognitive health: A comprehensive review	17